Albion Financial Group Bristol Myers Squibb CO Transaction History

Albion Financial Group

$1.42 Billion
Q3 2024

A detailed history of Albion Financial Group transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Albion Financial Group holds 1,200 shares of BMY stock, worth $69,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,200

Previous 1,200 -0.0%

Holding current value

$69,876

Previous $49,000 26.53%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 10, 2024	SELL	$40.25 - $52.99 $31,596 - $41,597	-785 Reduced 39.55%	1,200 $49,000
Q1 2024 Apr 19, 2024	BUY	$47.98 - $54.4 $35,697 - $40,473	744 Added 59.95%	1,985 $107,000
Q4 2023 Jan 26, 2024	BUY	$48.48 - $57.85 $1,987 - $2,371	41 Added 3.42%	1,241 $63,000
Q4 2022 Feb 03, 2023	SELL	$68.48 - $81.09 $16,777 - $19,867	-245 Reduced 16.96%	1,200 $86,000
Q3 2022 Oct 27, 2022	SELL	$0.13 - $76.84 $52 - $31,043	-404 Reduced 21.85%	1,445 $103,000
Q2 2022 Jul 29, 2022	BUY	$72.62 - $79.98 $72 - $79	1 Added 0.05%	1,849 $142,000
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $61 - $73	1 Added 0.05%	1,848 $135,000
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $21,398 - $24,945	-399 Reduced 17.76%	1,847 $115,000
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $123 - $134	2 Added 0.09%	2,246 $150,000
Q4 2020 Feb 19, 2021	BUY	$57.74 - $65.43 $129,568 - $146,824	2,244 New	2,244 $139,000
Q4 2018 Jan 28, 2019	SELL	$48.76 - $63.23 $2.36 Million - $3.07 Million	-48,476 Closed	0 $0
Q3 2018 Nov 20, 2018	SELL	$55.19 - $62.25 $167,391 - $188,804	-3,033 Reduced 5.89%	48,476 $3.01 Million
Q2 2018 Aug 15, 2018	BUY	$50.53 - $62.98 $11,874 - $14,800	235 Added 0.46%	51,509 $2.85 Million
Q1 2018 Apr 17, 2018	SELL	$59.92 - $68.98 $13,721 - $15,796	-229 Reduced 0.44%	51,274 $3.24 Million
Q4 2017 Feb 22, 2018	SELL	$59.94 - $65.35 $17,322 - $18,886	-289 Reduced 0.56%	51,503 $3.16 Million
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $1.54 Million - $1.78 Million	27,960 Added 117.32%	51,792 $3.3 Million
Q2 2017 Aug 15, 2017	BUY	N/A	23,832	23,832 $1.33 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

News

Stay updated on Albion Financial Group with notifications on news.

Account

Albion Financial Group Bristol Myers Squibb CO Transaction History